CRIPTO3
geneOn this page
Also known as TDGF2CR-3CRIPTO-3
Summary
CRIPTO3 (cripto, EGF-CFC family member 3, HGNC:11703) is a protein-coding gene on chromosome Xq23, encoding Protein CRIPTO3 (P51864). Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm.
The TDGF3 locus has characteristics of a retrotransposon, including lack of introns and a poly(A) sequence.
Source: NCBI Gene 6998 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001397362
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11703 |
| Approved symbol | CRIPTO3 |
| Name | cripto, EGF-CFC family member 3 |
| Location | Xq23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TDGF2, CR-3, CRIPTO-3 |
| Ensembl gene | ENSG00000225366 |
| Ensembl biotype | protein_coding |
| Entrez | 6998 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000602699, ENST00000851044
RefSeq mRNA: 1 — MANE Select: NM_001397362
NM_001397362
CCDS: CCDS94651
Canonical transcript exons
ENST00000602699 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004283548 | 110520896 | 110523021 |
Expression profiles
Bgee: expression breadth broad, 23 present calls, max score 72.83.
Top tissues by expression
114 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 72.83 | gold quality |
| vastus lateralis | UBERON:0001379 | 64.98 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 50.25 | silver quality |
| adrenal tissue | UBERON:0018303 | 45.32 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.19 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 40.18 | gold quality |
| kidney | UBERON:0002113 | 38.78 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 38.73 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 37.43 | silver quality |
| left ovary | UBERON:0002119 | 37.30 | silver quality |
| ovary | UBERON:0000992 | 37.07 | silver quality |
| right lobe of liver | UBERON:0001114 | 36.57 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 36.24 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| endometrium | UBERON:0001295 | 35.48 | gold quality |
| muscle tissue | UBERON:0002385 | 34.99 | gold quality |
| apex of heart | UBERON:0002098 | 34.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 34.26 | gold quality |
| spleen | UBERON:0002106 | 33.90 | gold quality |
| right coronary artery | UBERON:0001625 | 33.64 | gold quality |
| monocyte | CL:0000576 | 33.27 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.18 | gold quality |
| adrenal gland | UBERON:0002369 | 33.06 | gold quality |
| bone marrow | UBERON:0002371 | 32.91 | gold quality |
| leukocyte | CL:0000738 | 32.76 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 32.67 | gold quality |
| blood | UBERON:0000178 | 32.65 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 69.38 |
| E-MTAB-9388 | yes | 11.65 |
| E-ANND-3 | yes | 3.76 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- CRIPTO-3, a processed pseudogene of CRIPTO-1 on the X chromosome, is expressed in undifferentiated NT2 cells and is regulated by germ cell nuclear factor in parallel to CRIPTO-1 (PMID:16954206)
- These data indicate that CRIPTO3 is an expressed gene, particularly in certain cancers, and suggest a potentially novel mechanism of oncogenesis through activation of a retrogene. (PMID:18835250)
- Pseudogene TDGF1P3 regulates the proliferation and metastasis of colorectal cancer cells via the miR-338-3p-PKM2 axis. (PMID:36436343)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cripto | ENSMUSG00000032494 |
| rattus_norvegicus | Cripto | ENSRNOG00000037171 |
Paralogs (5): CFC1 (ENSG00000136698), CFC1B (ENSG00000152093), EGFL7 (ENSG00000172889), CRIPTO (ENSG00000241186), EGFL8 (ENSG00000241404)
Protein
Protein identifiers
Protein CRIPTO3 — P51864 (reviewed: P51864)
Alternative names: Cripto, EGF-CFC family member 3, Cripto-3 growth factor, Epidermal growth factor-like cripto protein CR3, Teratocarcinoma-derived growth factor 1 pseudogene 3, Teratocarcinoma-derived growth factor 3
All UniProt accessions (1): P51864
UniProt curated annotations — full annotation on UniProt →
Function. Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm. Activates the Nodal-dependent signaling pathway.
Subcellular location. Cell membrane.
Tissue specificity. Expressed weakly in lung, colon and breast. Expressed also strongly in primary cancer tissues; lung and colon cancers.
Similarity. Belongs to the EGF-CFC (Cripto-1/FRL1/Cryptic) family.
RefSeq proteins (1): NP_001384291* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000742 | EGF | Domain |
| IPR017047 | Cripto | Family |
| IPR019011 | Cryptic/Cripto_CFC-dom | Domain |
Pfam: PF09443
UniProt features (9 total): disulfide bond 6, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P51864-F1 | 66.63 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (6): 82–89, 83–95, 97–106, 115–133, 128–149, 131–140
Glycosylation sites (1): 79
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-1181150 | Signaling by NODAL |
| R-HSA-1433617 | Regulation of signaling by NODAL |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 27 (showing top):
GOCC_CELL_SURFACE, GOMF_GROWTH_FACTOR_ACTIVITY, GOBP_SPECIFICATION_OF_SYMMETRY, HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN, GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION, GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY, GOMF_SIGNALING_RECEPTOR_BINDING, BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP, GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT, GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING, GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY, chrXq23, GOBP_NODAL_SIGNALING_PATHWAY, REACTOME_REGULATION_OF_SIGNALING_BY_NODAL, GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY
GO Biological Process (6): blood vessel development (GO:0001568), signal transduction (GO:0007165), determination of left/right symmetry (GO:0007368), heart development (GO:0007507), anterior/posterior pattern specification (GO:0009952), nodal signaling pathway (GO:0038092)
GO Molecular Function (3): growth factor activity (GO:0008083), nodal binding (GO:0038100), activin receptor binding (GO:0070697)
GO Cellular Component (4): extracellular region (GO:0005576), plasma membrane (GO:0005886), cell surface (GO:0009986), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
| Signaling by NODAL | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| vasculature development | 1 |
| anatomical structure development | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| determination of bilateral symmetry | 1 |
| left/right pattern formation | 1 |
| animal organ development | 1 |
| circulatory system development | 1 |
| regionalization | 1 |
| activin receptor signaling pathway | 1 |
| receptor ligand activity | 1 |
| protein binding | 1 |
| transmembrane receptor protein serine/threonine kinase binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A8M9PDM1, A0A8M9QN10, A1L3I3, A2AWH2, A2CI97, A2CI98, A4IFM1, A4IHZ3, A7E2V4, A7E305, B1AL88, B6CKP4, E7F211, F8W3R9, O55034, O94901, P35054, P51864, P86275, P98153, P98154, Q0VCT2, Q3UHH1, Q498C7, Q4KM46, Q4TUC0, Q58T08, Q5EB20, Q5HZE8, Q5RD34, Q5VUB5, Q6UW32, Q6V9Y8, Q7TNI2, Q7Z5A8, Q80ZA7, Q86VZ4, Q8CB67, Q8CCS2, Q8N0W7
Diamond homologs: P0CG36, P0CG37, P13385, P51864, P51865, P97766, Q9I8Q3, O88277, Q5F226, A0A2K5V015, Q5R6R1, Q5T1H1, O97507, Q20911
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000625825 (X:110519091 C>T), RS1000921116 (X:110523048 G>A), RS1000928093 (X:110519537 G>A), RS1002047432 (X:110520494 G>A), RS1002163619 (X:110520047 G>A), RS1007035247 (X:110519675 T>C), RS1007472542 (X:110519123 T>C,G), RS1007779612 (X:110522214 T>C), RS1008202807 (X:110519477 T>C), RS1008570735 (X:110520854 C>A,T), RS1008651568 (X:110519004 C>A), RS1008951294 (X:110523042 C>T), RS1009374404 (X:110519972 G>A), RS1010361744 (X:110520394 T>C), RS1010477803 (X:110519802 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001612_10 | Sex hormone-binding globulin levels | 3.000000e-16 |
| GCST001612_14 | Sex hormone-binding globulin levels | 4.000000e-14 |
| GCST90002397_161 | Mean spheric corpuscular volume | 3.000000e-28 |
| GCST90011766_6 | Glaucoma (primary open-angle) | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004696 | sex hormone-binding globulin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Tretinoin | affects binding, increases reaction | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): open-angle glaucoma